Horizon denies allegations

Horizon Pharma (Nasdaq: HZNP) issued a statement denying allegations that it owned specialty pharmacies that sold its products and clarifying that the average prices of DUEXIS, VIMOVO, PENNSAID and RAYOS have not increased over the past year. The stock price soared $3.94 to close at $17.06.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.